Electrophysiological characterization of BRL-32872 in canine Purkinje fiber and ventricular muscle. Effect on early after-depolarizations and repolarization dispersion
- PMID: 10585537
- DOI: 10.1016/s0014-2999(99)00614-7
Electrophysiological characterization of BRL-32872 in canine Purkinje fiber and ventricular muscle. Effect on early after-depolarizations and repolarization dispersion
Abstract
Amongst the different pharmacological approaches to the treatment of cardiac arrhythmias, compounds with multiple electrophysiological activities appear to exhibit a reduced adverse effect profile. BRL-32872 (N-(3,4-dimethoxyphenyl)-N-[3[[2-(3,4-dimethoxyphenyl) ethyl] propyl]-4-nitrobenzamide hydrochloride) is a typical example of an antiarrhythmic agent with combined K(+) and Ca(2+) blocking actions. In this study, we investigated the effects of BRL-32872 on early after-depolarizations and on dispersion of repolarization. Action potentials were recorded either in canine cardiac Purkinje fibers alone or in preparations containing both ventricular muscle and the attached Purkinje fibers. In Purkinje fibers, BRL-32872 (0. 3-10 microM) induced a bell-shaped concentration-dependent increase in action potential duration. At 90% of repolarization, the action potential was prolonged at concentrations up to 1 microM and was shortened when the concentration of BRL-32872 was further increased. In all 17 experiments, BRL-32872 did not cause early after-depolarizations in Purkinje fibers. On the contrary, BRL-32872 (3 microM) systematically suppressed early after-depolarizations induced by clofilium (4-chloro-N, N-diethyl-N-heptylbenzenebutanaminium tosylate, 1 microM), a selective inhibitor of the delayed rectifier K(+) current. A similar effect was observed once with 1 microM BRL-32872, a concentration able to prolong Purkinje fiber action potentials. Simultaneous recording of action potentials in ventricular and Purkinje preparations showed that increasing concentrations of BRL-32872 (0. 3-10 microM) induced a limited increase in the difference of repolarization time between the two tissues. The selective K(+) channel inhibitor E-4031 (N-(4-(1-[2-(6-methyl-2-pyridyl) ethyl]-4-piperidyl)-carbonyl] phenyl) methanesulfonamide dihydrochloride dihydrate) exhibited a significant concentration-dependent increase in dispersion of repolarization. We conclude from the present results that the Ca(2+) blocking activity of BRL-32872 (i) prevents the occurrence of early after-depolarizations associated with action potential prolongation and (ii) limits an excessive increase in action potential duration heterogeneity. These electrophysiological features might represent the basis for antiarrhythmic compounds with reduced proarrhythmic profile.
Similar articles
-
Electrophysiological effect of BRL-32872, a novel antiarrhythmic agent with potassium and calcium channel blocking properties, in guinea pig cardiac isolated preparations.J Pharmacol Exp Ther. 1995 Jun;273(3):1264-72. J Pharmacol Exp Ther. 1995. PMID: 7791099
-
Analysis of the electrophysiological effects of ambasilide, a new antiarrhythmic agent, in canine isolated ventricular muscle and purkinje fibers.Gen Pharmacol. 2000 Feb;34(2):85-93. doi: 10.1016/s0306-3623(00)00048-3. Gen Pharmacol. 2000. PMID: 10974415
-
Cellular electrophysiological effect of terikalant in the dog heart.Eur J Pharmacol. 2005 Mar 14;510(3):161-6. doi: 10.1016/j.ejphar.2004.12.040. Eur J Pharmacol. 2005. PMID: 15763239
-
The antiarrhythmic drug BRL-32872.Cardiovasc Drug Rev. 2002 Summer;20(2):111-20. doi: 10.1111/j.1527-3466.2002.tb00186.x. Cardiovasc Drug Rev. 2002. PMID: 12177689 Review.
-
A classification of antiarrhythmic actions reassessed after a decade of new drugs.J Clin Pharmacol. 1984 Apr;24(4):129-47. doi: 10.1002/j.1552-4604.1984.tb01822.x. J Clin Pharmacol. 1984. PMID: 6144698 Review.
Cited by
-
Voltage Imaging of Cardiac Cells and Tissue Using the Genetically Encoded Voltage Sensor Archon1.iScience. 2020 Apr 24;23(4):100974. doi: 10.1016/j.isci.2020.100974. Epub 2020 Mar 11. iScience. 2020. PMID: 32299055 Free PMC article.
-
Electromechanical and atrial and ventricular antiarrhythmic actions of CIJ-3-2F, a novel benzyl-furoquinoline vasodilator in rat heart.Br J Pharmacol. 2014 Aug;171(16):3918-37. doi: 10.1111/bph.12752. Br J Pharmacol. 2014. PMID: 24820856 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous